SAREPTA THERAPEUTICS, INC. Fair Value Assumptions, Expected Dividend Rate (Deprecated 2018-01-31)
SAREPTA THERAPEUTICS, INC. (SRPT) reported Fair Value Assumptions, Expected Dividend Rate (Deprecated 2018-01-31) of 0.00% for the 6-month period ending 2014-06-30, per its 10-Q filed 2014-08-07.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueAssumptionsExpectedDividendRate · last filed 2014-08-07
- SAREPTA THERAPEUTICS, INC. fair value assumptions, expected dividend rate (deprecated 2018-01-31) for the quarter ending 2014-03-31 was 0.00%.
- SAREPTA THERAPEUTICS, INC. fair value assumptions, expected dividend rate (deprecated 2018-01-31) for the quarter ending 2013-03-31 was 0.00%.
- SAREPTA THERAPEUTICS, INC. fair value assumptions, expected dividend rate (deprecated 2018-01-31) for the quarter ending 2012-09-30 was 0.00%.
- SAREPTA THERAPEUTICS, INC. fair value assumptions, expected dividend rate (deprecated 2018-01-31) for the quarter ending 2012-06-30 was 0.00%.
- SAREPTA THERAPEUTICS, INC. fair value assumptions, expected dividend rate (deprecated 2018-01-31) for fiscal 2012 was 0.00%.
- SAREPTA THERAPEUTICS, INC. fair value assumptions, expected dividend rate (deprecated 2018-01-31) for fiscal 2011 was 0.00%.
- SAREPTA THERAPEUTICS, INC. fair value assumptions, expected dividend rate (deprecated 2018-01-31) for fiscal 2010 was 0.00%.
| Period end | Fair Value Assumptions, Expected Dividend Rate (Deprecated 2018-01-31) 3 month | Fair Value Assumptions, Expected Dividend Rate (Deprecated 2018-01-31) 6 month | Fair Value Assumptions, Expected Dividend Rate (Deprecated 2018-01-31) 9 month | Fair Value Assumptions, Expected Dividend Rate (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2014-06-30 | 0.00% 10-Q · filed 2014-08-07 | |||
| 2014-03-31 | 0.00% 10-Q · filed 2014-05-08 | |||
| 2013-12-31 | 0.00% 10-Q · filed 2014-08-07 | |||
| 2013-09-30 | 0.00% 10-Q · filed 2013-11-12 | |||
| 2013-06-30 | 0.00% 10-Q · filed 2013-08-08 | |||
| 2013-03-31 | 0.00% 10-Q · filed 2014-05-08 | |||
| 2012-12-31 | 0.00% 10-K · filed 2014-03-03 | |||
| 2012-09-30 | 0.00% 10-Q · filed 2012-11-07 | 0.00% 10-Q · filed 2012-11-07 | ||
| 2012-06-30 | 0.00% 10-Q · filed 2012-08-07 | 0.00% 10-Q · filed 2012-08-07 | ||
| 2012-03-31 | 0.00% 10-Q · filed 2013-05-09 | |||
| 2011-12-31 | 0.00% 10-K · filed 2014-03-03 | |||
| 2011-09-30 | 0.00% 10-Q · filed 2012-11-07 | 0.00% 10-Q · filed 2012-11-07 | ||
| 2011-06-30 | 0.00% 10-Q · filed 2012-08-07 | 0.00% 10-Q · filed 2012-08-07 | ||
| 2010-12-31 | 0.00% 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |